The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.

Saved in:
Bibliographic Details
Title: The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Authors: Copaescu A; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Clinical Immunology and Allergy, Department of Medicine, McGill University Health Center, Montréal, QC, Canada.; The Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada., James F; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia., Mouhtouris E; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia., Vogrin S; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, VIC, Australia., Smibert OC; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia., Gordon CL; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Microbiology and Immunology, The University of Melbourne, Parkville, VIC, Australia., Drewett G; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia., Holmes NE; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Critical Care, Melbourne Medical School, The University of Melbourne, Parkville, VIC, Australia., Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, VIC, Australia.; Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.; Department of Oncology, Sir Peter MacCallum Cancer Centre, The University of Melbourne, Parkville, VIC, Australia.; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
Source: Frontiers in immunology [Front Immunol] 2021 Mar 17; Vol. 12, pp. 646095. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first